NCT04157686: A reported trial by Medy-Tox
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04157686 |
|---|---|
| Title | A Multicenter, Long-term, Open-label Study to Evaluate the Safety of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines and Lateral Canthal Lines |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 23, 2019 |
| Completion date | Feb. 16, 2023 |
| Required reporting date | Feb. 16, 2026, midnight |
| Actual reporting date | July 4, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |